SCHEMBL19207613

SCHEMBL19207613

CN1C(=O)C(NC(=O)c2nnc(Cc3cccc(C#N)c3)[nH]2)COc2cccnc21

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29415769 1.00 RIPK1 (0.76) RIPK1
SCHEMBL19207609 1.00 RIPK1 (0.76) RIPK1
SCHEMBL22736919 0.93 RIPK1 (0.67) RIPK1
SCHEMBL22737150 0.93 RIPK1 (0.67) RIPK1
SCHEMBL19224733 0.92 RIPK1 (0.65) RIPK1
SCHEMBL29415739 0.90 RIPK1 (0.77) RIPK1
SCHEMBL19207842 0.90 RIPK1 (0.77) RIPK1
SCHEMBL19207838 0.90 RIPK1 (0.77) RIPK1
SCHEMBL19207737 0.88 RIPK1 (0.75) RIPK1
SCHEMBL29415655 0.88 RIPK1 (0.75) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed